CAS 2009-64-5|D-erythro-Neopterin
| Common Name | D-erythro-Neopterin | ||
|---|---|---|---|
| CAS Number | 2009-64-5 | Molecular Weight | 253.215 |
| Density | 2.0±0.1 g/cm3 | Boiling Point | 697.7ºC at 760mmHg |
| Molecular Formula | C9H11N5O4 | Melting Point | >232ºC (dec.) |
| MSDS | ChineseUSA | Flash Point | 375.7ºC |
| Symbol | GHS07 | Signal Word | Warning |
Names
| Name | d-(+)-neopterin |
|---|---|
| Synonym | More Synonyms |
D-erythro-Neopterin BiologicalActivity
| Description | D-(+)-Neopterin, a catabolic product of guanosine triphosphate (GTM), serves as a marker of cellular immune system activation. |
|---|---|
| Related Catalog | Research Areas >>Inflammation/ImmunologyNatural Products >>Saccharides and Glycosides |
| Target | Human Endogenous Metabolite |
| References | [1]. Murr C, et al. Neopterin as a Marker for Immune System Activation. Current Drug Metabolism [01 Apr 2002, 3(2):175-187]. |
Chemical & Physical Properties
| Density | 2.0±0.1 g/cm3 |
|---|---|
| Boiling Point | 697.7ºC at 760mmHg |
| Melting Point | >232ºC (dec.) |
| Molecular Formula | C9H11N5O4 |
| Molecular Weight | 253.215 |
| Flash Point | 375.7ºC |
| Exact Mass | 253.081100 |
| PSA | 158.50000 |
| LogP | -4.57 |
| Index of Refraction | 1.860 |
Safety Information
| Symbol | GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi: Irritant; |
| Risk Phrases | 36/37/38 |
| Safety Phrases | 26 |
| RIDADR | NONH for all modes of transport |
| HS Code | 2933990090 |
Customs
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Articles37
More Articles| Increased serum levels of quinolinic acid indicate enhanced severity of hepatic dysfunction in patients with liver cirrhosis. Hum. Immunol. 74(1) , 60-6, (2013) The Model for End-Stage Liver Disease (MELD) score is a tool for assessment of the degree of hepatic insufficiency/failure. Quinolinic acid (QuinA) is a tryptophan metabolite produced by activated mac... | |
| A community-based study on determinants of circulating markers of cellular immune activation and kynurenines: the Hordaland Health Study. Clin. Exp. Immunol. 173(1) , 121-30, (2013) Circulating neopterin and kynurenine/tryptophan ratio (KTR) increase during inflammation and serve as markers of cellular immune activation, but data are sparse on other determinants of these markers ... | |
| Interferon (IFN)-γ-mediated inflammation and the kynurenine pathway in relation to bone mineral density: the Hordaland Health Study. Clin. Exp. Immunol. 176(3) , 452-60, (2014) The risk of osteoporosis increases in inflammatory disorders. In cell-mediated immune activation, interferon (IFN)-γ stimulates macrophage release of neopterin and increases the activity of indoleamin... |
Synonyms
| 2-Amino-6-[(1S,2R)-1,2,3-trihydroxypropyl]-4(1H)-pteridinone |
| Crithidia Factor |
| 2-Amino-6-[(1S,2R)-1,2,3-trihydroxypropyl]pteridin-4(3H)-one |
| 1-(2-amino-4-hydroxy-pteridin-6-yl)propane-1,2,3-triol |
| EINECS 217-924-7 |
| 2-Amino-6-[(1S,2R)-1,2,3-trihydroxypropyl]pteridin-4(8H)-one |
| D-Neopterin |
| 2-Amino-6-[(1S,2R)-1,2,3-trihydroxypropyl]-4(1H)-ptéridinone |
| MFCD00042801 |
| 4(8H)-pteridinone, 2-amino-6-[(1S,2R)-1,2,3-trihydroxypropyl]- |
| 6-(1',2',3'-Trihydroxy)pterin |
| D(+)-Neopterin 10MG |
| D(+)-6-(ERYTHRO-1,2,3-TRIHYDROXYPROPYL)PTERIN |
| D-neopterine |
| Gavestinel |
| D-(+)-Neopterin |
| D-(PLUS)-NEOPTERINE |
| 2-amino-6-((1S,2R)-1,2,3-trihydroxy-propyl)-3H-pteridin-4-one |
| (+)-NEOPTERIN |
| D-erythro-neopterin |
| 4(3H)-Pteridinone, 2-amino-6-[(1S,2R)-1,2,3-trihydroxypropyl]- |
| 2-Amino-6-[(1S,2R)-1,2,3-trihydroxypropyl]-4(1H)-pteridinon |
| Neopterin |
| D(+)-Neopterin |
| 2-amino-6-(1,2,3-trihydroxy-propyl)-3H-pteridin-4-one |
| 2-AMino-6-[(1S,2R)-1,2,3-trihydroxypropyl] |
